Crescent Biopharma Alternatives & Competitors
12 companies similar to Crescent Biopharma — Delivering the next wave of transformative therapies to bring a brighter future...
Companies similar to Crescent Biopharma
Genmab
Differentiated human antibody therapeutics for the treatment of cancer
Denmark
Elevation Oncology
We are focused on discovering and developing selective cancer therapies to treat patients...
Boston, United States
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
Compass Therapeutics Inc.
We are developing next-generation antibodies into transformative cancer therapies that imp...
Boston, United States
Track all Crescent Biopharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Acepodia
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
Alameda, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Myricx Bio
Developing a new class of ADCs based on NMT inhibition to treat cancer
London, United Kingdom
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
Arcus Biosciences
Global, biopharmaceutical company at the forefront of designing precision combinations in...
Hayward, United States
About Crescent Biopharma
Crescent Biopharma is striving to be a pioneer in the field of oncology, focusing on developing next-generation therapies to combat cancer. Its slogan, "Delivering the next wave of transformative therapies to bring a brighter future for people living with cancer," underscores its commitment to innovation and patient we...
Research and Development of Cancer Therapies, Clinical Trials, Drug Development and Commercialization
Oncology Patients, Healthcare Providers, Clinical Researchers, Investors in Biotechnology
Oncology, Cancer Treatment, Biopharmaceuticals, Clinical-stage Pipeline, PD-1 X VEGF Bispecific Antibody, Antibody-drug Conjugates, Solid Tumors, Therapeutic Modalities, Combination Regimens, Transformative Therapies, Biotech Innovation, Biospecific Antibody Development
B2B, B2G, B2B2C
Product Sales, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Crescent Biopharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Crescent Biopharma on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 25 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
